{
    "paper_id": "00d5f53fcff261c7ccd4d5adf5524a0e94d2112c",
    "metadata": {
        "title": "SARS-CoV-2 breakthrough infections in vaccinated kidney transplant recipients: an issue of concern",
        "authors": [
            {
                "first": "Veerle",
                "middle": [],
                "last": "Wijtvliet",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Antwerp University Hospital",
                    "location": {
                        "settlement": "Antwerp",
                        "country": "Belgium"
                    }
                },
                "email": "veerle.wijtvliet@uantwerpen.be"
            },
            {
                "first": "Kristien",
                "middle": [],
                "last": "Ledeganck",
                "suffix": "",
                "affiliation": {
                    "laboratory": "Laboratory of Experimental Medicine and Pediatrics",
                    "institution": "University of Antwerp",
                    "location": {
                        "settlement": "Antwerp",
                        "country": "Belgium"
                    }
                },
                "email": ""
            },
            {
                "first": "Bart",
                "middle": [],
                "last": "Peeters",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Antwerp University Hospital",
                    "location": {
                        "settlement": "Antwerp",
                        "country": "Belgium Correspondence"
                    }
                },
                "email": ""
            },
            {
                "first": "Rachel",
                "middle": [],
                "last": "Hellemans",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Antwerp University Hospital",
                    "location": {
                        "settlement": "Antwerp",
                        "country": "Belgium"
                    }
                },
                "email": ""
            },
            {
                "first": "Daniel",
                "middle": [],
                "last": "Abramowicz",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Antwerp University Hospital",
                    "location": {
                        "settlement": "Antwerp",
                        "country": "Belgium"
                    }
                },
                "email": ""
            }
        ]
    },
    "abstract": [],
    "body_text": [
        {
            "text": "With efficacies up to 95% reported in the general population, vaccination against SARS-CoV-2 seems to be the holy grail to solve the ongoing pandemic (1) . Nevertheless, recent reports have shown lower efficacies in kidney transplant recipients. In a cohort of 322 kidney transplant recipients only 48% showed anti-spike seroconversion 29 days after two doses of mRNA vaccine (2) . This raises concerns regarding SARS-CoV-2 breakthrough infections in this vulnerable population, as shown in several recent reports (3) (4) (5) .",
            "cite_spans": [
                {
                    "start": 150,
                    "end": 153,
                    "text": "(1)",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 376,
                    "end": 379,
                    "text": "(2)",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 514,
                    "end": 517,
                    "text": "(3)",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 518,
                    "end": 521,
                    "text": "(4)",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 522,
                    "end": 525,
                    "text": "(5)",
                    "ref_id": "BIBREF4"
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "We here report a case of a 23-year old kidney transplant recipient (transplanted in 2020) who developed a moderate Covid-19 infection 6 weeks after receiving two doses of BNT162b2 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Testing was repeated 19 days after the PCR-confirmed SARS-CoV-2 infection. Surprisingly, it showed the presence of anti-SARS-CoV-2 spike IgG antibodies at a titre of 15.50 U/mL (cutoff value for positivity \u2265 1 U/ml).",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 180,
                    "end": 409,
                    "text": "1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60",
                    "ref_id": null
                }
            ],
            "section": ""
        },
        {
            "text": "In summary, despite the lack of immune response to the SARS-CoV-2 vaccine, the patient did develop a strong antibody response to SARS-CoV-2 infection. Better anti-SARS-CoV-2 antibody responses have been described after infection (7) versus vaccination (2) in kidney transplant recipients. One may speculate that the reduction of the immunosuppressive therapy following confirmed SARS-CoV-2 diagnosis facilitated antibody production. The second issue is the presence of the Alpha (British) variant, suggesting that patients with low/non-detectable antibody production might be particularly susceptible to infection by variant strains (5) .",
            "cite_spans": [
                {
                    "start": 633,
                    "end": 636,
                    "text": "(5)",
                    "ref_id": "BIBREF4"
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "Kidney transplant recipients should therefore continue to adhere to all safety and hygienic measures. There is an urgent need for studies that intend to improve vaccination responses in this vulnerable population. 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 ",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 214,
                    "end": 437,
                    "text": "3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60",
                    "ref_id": null
                }
            ],
            "section": ""
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Dagan",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Barda",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Kepten",
                    "suffix": ""
                }
            ],
            "year": 2021,
            "venue": "New England Journal of Medicine",
            "volume": "384",
            "issn": "15",
            "pages": "1412--1423",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients",
            "authors": [
                {
                    "first": "B",
                    "middle": [
                        "J"
                    ],
                    "last": "Boyarsky",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "A"
                    ],
                    "last": "Werbel",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "K"
                    ],
                    "last": "Avery",
                    "suffix": ""
                }
            ],
            "year": 2021,
            "venue": "JAMA",
            "volume": "325",
            "issn": "21",
            "pages": "2204--2206",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Severe consequences of COVID-19 infection among vaccinated kidney transplant recipients",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Tau",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Yahav",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Schneider",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Rozen-Zvi",
                    "suffix": ""
                },
                {
                    "first": "Abu",
                    "middle": [],
                    "last": "Sneineh",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Rahamimov",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "American Journal of Transplantation",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Clinically Significant COVID-19 Following SARS-CoV-2 Vaccination in Kidney Transplant Recipients",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Tsapepas",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Paget",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Mohan",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "J"
                    ],
                    "last": "Cohen",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "A"
                    ],
                    "last": "Husain",
                    "suffix": ""
                }
            ],
            "year": 2021,
            "venue": "Am J Kidney Dis",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Occurrence of severe COVID-19 in vaccinated transplant patients",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Caillard",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Chavarot",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Bertrand",
                    "suffix": ""
                }
            ],
            "year": 2021,
            "venue": "Kidney Int",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "Rouphael NG; Immune Responses to SARS-CoV-2 in Solid Organ Transplant Recipients",
            "authors": [
                {
                    "first": "V",
                    "middle": [
                        "K"
                    ],
                    "last": "Phadke",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Scanlon",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "C"
                    ],
                    "last": "Jordan",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Current transplantation reports",
            "volume": "2021",
            "issn": "",
            "pages": "1--13",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "Pfizer-BioNTech) vaccine. The vaccine was administered on March 17th 2021 and April 9th 2021. The immunosuppressive protocol consisted of sirolimus (target trough levels: 5-7 ng/ml), mycophenolate mofetil (1 g/day), and prednisolone (5 mg/day). Forty-one days after the second vaccination, the patient tested positive for SARS-CoV-2 by PCR, corresponding to a vaccine breakthrough infection according to the recent CDC-definition (SARS-CoV-2 RNA or antigen in a respiratory specimen \u2265 14 days after complete vaccination) (6). Eleven days later the patient presented at the emergency department with fever up to 39 \u00b0C and diarrhoea. Computed tomography of the chest showed bilateral pneumonia, compatible with COVID-19 pneumonia, requiring supplemental oxygen therapy. Mycophenolate mofetil was interrupted and steroids dose was increased to 20 mg/day. Viral sequencing of bronchoalveolar lavage sample showed the presence of the Alpha (British) variant of SARS-CoV-2 (N501Y mutation).Serum anti-SARS-CoV-2 spike IgG antibody testing (Atellica IM SARS-CoV-2 IgG (sCOVG) assay) 21 days after first dose and 26 days after second dose vaccination was negative.",
            "latex": null,
            "type": "figure"
        }
    },
    "back_matter": []
}